tiprankstipranks
Portage Biotech Inc (PRTG)
NASDAQ:PRTG
US Market
Holding PRTG?
Track your performance easily

Portage Biotech Inc (PRTG) Financial Statements

74 Followers

Portage Biotech Inc Financial Overview

Portage Biotech Inc's market cap is currently ―. The company's EPS TTM is $-70.217; its P/E ratio is -0.06; Portage Biotech Inc is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-$ -48.87M$ -6.06M--
EBITDA-$ -48.85M$ -6.06M--
Net Income Common Stockholders-$ -39.38M$ -5.16M--
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 5.03M$ 5.34M$ 3.44M$ 10.54M$ 13.10M
Total Assets$ 7.78M$ 49.03M$ 92.40M$ 99.13M$ 210.68M
Total Debt$ 47.00K$ 275.00K$ 286.00K$ 0.00$ 0.00
Net Debt$ -4.98M$ -5.07M$ -3.16M$ -10.54M$ -13.10M
Total Liabilities$ 4.45M$ 17.70M$ 25.40M$ 23.73M$ -21.01M
Stockholders Equity$ 4.02M$ 32.00M$ 67.66M$ 76.05M$ 237.17M
Cash Flow-
Free Cash Flow-$ -3.43M---
Operating Cash Flow-$ -3.43M---
Investing Cash Flow-----
Financing Cash Flow-$ 5.33M---
Currency in USD

Portage Biotech Inc Earnings and Revenue History

Portage Biotech Inc Debt to Assets

Portage Biotech Inc Cash Flow

Portage Biotech Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis